4-Amino-3-Chlorophenol CAS 17609-80-2 Lenvatinib Mesylate daahirnimada dhexe>99.0% (HPLC)

Sharaxaad Gaaban:

Magaca Kiimikada: 4-Amino-3-Chlorophenol

CAS: 17609-80-2

Daahirsanaanta:>99.0% (HPLC)

Muuqaalka: Budada Adag ee Brown

Dhexdhexaadiyaha Lenvatinib Mesylate CAS 857890-39-2

Xiriirka: Dr. Alvin Huang

Mobile/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com


Faahfaahinta Alaabta

Alaabooyinka La Xiriira

Tags Product

Sharaxaad:

Guryaha Kiimikada:

Magaca Kiimikada 4-Amino-3-Chlorophenol
La mid ah 3-Chloro-4-Aminophenol;Lenvaint-G
Lambarka CAS 17609-80-2
Lambarka CAT RF-PI1968
Heerka Saamiyada Kaydka dhexdiisa, Qiyaasta Waxsoosaarka Ilaa Tan
Qaanuunka molecular C6H6ClNO
Miisaanka Molecular 143.57
Cufnaanta 1.406 ± 0.060 g / cm3
Summada Kiimikada Ruifu

Tilmaamaha:

Shayga Tilmaamaha
Muuqashada Budada Adag ee Brown
1 H NMR Spectrum Waafaqsan Qaab-dhismeedka
Aqoonsiga-HPLC Waqtiga haynta la mid ah heerka caadiga ah
Daahirnimada / Habka Falanqaynta >99.0% (HPLC)
Meesha dhalaalaysa 138.0 ~ 141.0 ℃
Khasaare xagga qalajinta <1.00%
Hadhaaga dabka <0.30%
Wadarta wasakhda <1.00%
Heerka Imtixaanka Heerka Ganacsiga
Isticmaalka Dhexdhexaadiyaha Lenvatinib Mesylate (CAS: 857890-39-2)

Xidhmada & Kaydinta:

Xidhmada: Dhalo, bacda bireed aluminium, 25kg / Durbaan kartoonada, ama sida waafaqsan shuruudaha macmiilka

Xaaladda Kaydinta:Ku kaydi weelasha xiran meel qabow oo qallalan;Ka ilaali iftiinka iyo qoyaanka

Faa'iidooyinka

1

FAQ:

Codsiga:

4-Amino-3-Chlorophenol (CAS: 17609-80-2) waa dhexdhexaad dawo oo muhiim ah, kaas oo si weyn loogu isticmaalo naqshadeynta iyo isku-darka ka-hortagga buro, cudurrada wadnaha iyo xididdada, daawooyinka cudurrada neerfaha.4-Amino-3-Chlorophenol waa dhexdhexaad muhiim u ah diyaarinta Lenvatinib Mesylate (CAS: 857890-39-2).Waxaa sameeyay Eisai Inc., lenvatinib mesylate waa vascular endothelial factor factor reseptor (VEGF) inhibitor kaas oo leh waxqabad ka dhan ah VEGF subtypes 1, 2, iyo 3 waxaana ansixiyay FDA 2015 si loogu daaweeyo kansarka qanjirka thyroid ee kala duwan soo noqnoqda, metastatic, ama horusocod ah oo aan ka jawaabin daaweynta iodine radioactive.Bishii Maajo 2016, FDA waxay oggolaatay daawada sida isku-darka daaweynta weligeed ah ee daaweynta kansarka unugyada kelyaha ee horumarsan.Sababtoo ah VEGF (iyo fibroblast factor factor reseptors, oo loo yaqaan FGFRs) ayaa loo maleynayaa inay door ka ciyaaraan waddooyinka calaamadaha wadnaha, VEGF2R iyo FGFR waxay u maleynayaan inay yihiin hababka ka dambeeya saameynta asaasiga ah ee lenvatinib mesylate, taas oo ah hypertension.

Halkan ku qor fariintaada oo noo soo dir